-
Mashup Score: 31Ivermectin for COVID-19: real-time meta analysis of 76 studies - 2 year(s) ago
76 ivermectin COVID-19 controlled studies. Early treatment – 66% improvement, p < 0.0001. Prophylaxis - 83% improvement, p < 0.0001. All studies - 65% improvement, p < 0.0001.
Source: ivmmeta.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 17Ivermectin for COVID-19: real-time meta analysis of 66 studies - 2 year(s) ago
66 ivermectin COVID-19 controlled studies. Early treatment – 67% improvement, p < 0.0001. Prophylaxis - 85% improvement, p < 0.0001. All studies - 67% improvement, p < 0.0001.
Source: ivmmeta.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @AviBittMD: https://t.co/ERVZAWAHR0 confirmed making things up. They claim 2 out of the 3 (out of 4 on my new analysis) of the high Stro…
-
-
Mashup Score: 4Ivermectin for COVID-19: real-time meta analysis of 65 studies - 3 year(s) ago
65 ivermectin COVID-19 controlled studies. Early treatment – 67% improvement, p < 0.0001. Prophylaxis - 86% improvement, p < 0.0001. All studies - 66% improvement, p < 0.0001.
Source: ivmmeta.comCategories: Future of Medicine, Latest HeadlinesTweet-
Let’s discuss. Ivermectin for COVID-19: real-time meta analysis of 65 studies. #ivetmectin #COVID19 @MartyMakary @ScottGottliebMD #pharma https://t.co/xYJ5VXx4L0
-
-
Mashup Score: 8Ivermectin for COVID-19: real-time meta analysis of 64 studies - 3 year(s) ago
64 ivermectin COVID-19 controlled studies. Early treatment – 67% improvement, p < 0.0001. Prophylaxis - 86% improvement, p < 0.0001. All studies - 66% improvement, p < 0.0001.
Source: ivmmeta.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @jamesheathers: Ahh, the https://t.co/591C8IMdjG guy doesn't like the article. It's late - can someone tell me if there's anything here…
-
-
Mashup Score: 25Ivermectin for COVID-19: real-time meta analysis of 63 studies - 3 year(s) ago
63 ivermectin COVID-19 controlled studies. Early treatment – 66% improvement, p < 0.0001. Prophylaxis - 86% improvement, p < 0.0001. All studies - 65% improvement, p < 0.0001.
Source: ivmmeta.comCategories: Expert Picks, Latest HeadlinesTweet-
Amazing. Watching @drsanjaygupta lie to the world. My fellow Inteflex grad at @umichmedicine No data? How about https://t.co/ftZ6XYWyaT https://t.co/BS7tdcCdyC
-
-
Mashup Score: 638Ivermectin for COVID-19: real-time meta analysis of 63 studies - 3 year(s) ago
63 ivermectin COVID-19 controlled studies. Early treatment – 69% improvement, p < 0.0001. Prophylaxis - 86% improvement, p < 0.0001. All studies - 67% improvement, p < 0.0001.
Source: ivmmeta.comCategories: Expert Picks, Latest HeadlinesTweet-
@CMichaelGibson Is “any type” of medication one that the Nobel Prize of Medicine? Over 60 studies in COVID since early 2020? https://t.co/M5zKN7BRts
-
-
Mashup Score: 31Ivermectin for COVID-19: real-time meta analysis of 60 studies - 3 year(s) ago
Ivermectin for COVID-19. Early treatment – 74% improvement, p < 0.0001. All studies - 70% improvement, p < 0.0001. 1 in 193 billion probability results of the 60 studies are from an ineffective treatment (p = 5.2e-12).
Source: ivmmeta.comCategories: Latest Headlines, SurgeryTweet-
Ha! I should have noticed this about the https://t.co/XQyVUjiSt9 people doing all those "real time meta-analyses" of #ivermectin, #HydroxyChloroquine, and whatever supplements they claim cure #COVID19. https://t.co/yKWzt5MZsV
-
-
Mashup Score: 120Ivermectin for COVID-19: real-time meta analysis of 60 studies - 3 year(s) ago
Ivermectin for COVID-19. Early treatment – 74% improvement, p < 0.0001. All studies - 70% improvement, p < 0.0001. 1 in 193 billion probability results of the 60 studies are from an ineffective treatment (p = 5.2e-12).
Source: ivmmeta.comCategories: Latest Headlines, SurgeryTweet-
No. As @GidMK showed, https://t.co/XQyVUjiSt9 takes that list of studies and falsely and deceptively spins it into a body of data that strongly supports the efficacy and safety of #ivermectin for #COVID19 when the data do not support that. It's propaganda, lying with studies. https://t.co/CQSBx8P4md
-
-
Mashup Score: 3Ivermectin for COVID-19: real-time meta analysis of 60 studies - 3 year(s) ago
Ivermectin for COVID-19. Early treatment – 74% improvement, p < 0.0001. All studies - 70% improvement, p < 0.0001. 1 in 193 billion probability results of the 60 studies are from an ineffective treatment (p = 5.2e-12).
Source: ivmmeta.comCategories: Expert Picks, Latest HeadlinesTweet-
@VPrasadMDMPH https://t.co/mxD5l2e13J
-
-
Mashup Score: 33Ivermectin for COVID-19: real-time meta analysis of 60 studies - 3 year(s) ago
Ivermectin for COVID-19. Early treatment – 76% improvement, p < 0.0001. All studies - 71% improvement, p < 0.0001. 1 in 2 trillion probability results of the 60 studies are from an ineffective treatment (p = 4.5e-13).
Source: ivmmeta.comCategories: Expert Picks, Latest HeadlinesTweet-
From https://t.co/mxD5l2e13J a 1 in 2 trillion probability that the powerful role of Ivermectin in 60 human studies is not a real observation https://t.co/0KQHD5Qviv
-
The Forest Plot is biased to one side…in a Meta-analysis of 76 studies https://t.co/NSF4H4Nnc7